Algert Global’s NuCana NCNA Stock Holding History

Algert Global’s Portfolio NCNA Stock Details NCNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$48K	–	1266
2021 Q4	$48K	Buy	+4	New	+$50.3K	0.01%	936

Other funds holding NCNA

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Algert Global's NCNA Position: Q1 2022 in Review

Algert Global sold out of NuCana (NCNA) in Q1 2022, closing a stake of 4 shares — an estimated $48K sold.

Algert Global first reported a position in NCNA in Q4 2021 and held it in 1 quarter. The position peaked at $48K in Q4 2021. 27 funds tracked by Wall St. Rank hold NCNA as of Q1 2022.

Algert Global reported no remaining NuCana position as of Q1 2022 after selling out during the quarter.
Algert Global sold 4 NuCana shares in Q1 2022, an estimated $48K.
Algert Global first reported a position in NuCana in Q4 2021 and held it in 1 quarter.
Algert Global's NuCana position peaked at $48K in Q4 2021.
27 funds tracked by Wall St. Rank held NuCana as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.